Pulmonary metastasectomy in sarcoma-experiences with laser-assisted resection.

@article{Schmid2018PulmonaryMI,
  title={Pulmonary metastasectomy in sarcoma-experiences with laser-assisted resection.},
  author={Severin Schmid and Uyen-Thao Le and Christoph Zeisel and Benedikt Haager and Bernward Passlick},
  journal={Journal of thoracic disease},
  year={2018},
  volume={10 1},
  pages={
          314-320
        }
}
Background Previous data suggest a survival benefit in well selected patients with extrathoracic sarcoma after pulmonary metastasectomy. Different techniques have been described for pulmonary metastasectomy; however laser-assisted surgery (LAS) was suggested to provide the best outcome in patients with higher numbers of metastases. Methods Data were extracted from a prospectively maintained institutional database and a total of 83 patients who underwent pulmonary metastasectomy at our clinic… 

Figures and Tables from this paper

Lung Metastatectomy: Can Laser-Assisted Surgery Make a Difference?

LAS allows radical lung-parenchyma saving resection of a high number of lung metastases with similar survival to conventional methods, and is a safe procedure with a postoperative morbidity up to 24.2% and almost zero mortality.

Results of redo pulmonary metastasectomy

It is stated that redo lung metastasectomy is worthwhile when the lesions are resectable and the perioperative risk is low, and there are no “non-surgical” therapeutic options to replace redo pulmonary metastasectomies.

Is laser-assisted resection preferable to lobectomy for pulmonary metastasectomy?

It is believed that laser resection can be proposed as a reliable and advantageous lung-sparing technique, as an alternative to lobectomy for metastasectomy, when stapler wedge resection is not feasible.

Surgical Morbidity and Lung Function Changes After Laser–Assisted Pulmonary Metastasectomy: A Prospective Bicentric Study

LAS is a safe and effective method for PM even for higher numbers of metastases, with short duration of postoperative air leak and little morbidity, including changes of lung function after laser–assisted surgery.

Changes in the surgical treatment of pulmonary metastases during the last 12 years

During the last 12 years, there was a more than two-fold increase in the number of patients requiring surgery due to pulmonary metastases, and the ratio of VATS metastasectomy increased significantly as well (5.3% vs. 64.9%).

Local Effects of a 1940 nm Thulium-Doped Fiber Laser and a 1470 nm Diode Laser on the Pulmonary Parenchyma: An Experimental Study in a Pig Model

TDFL caused less thermal damage to the lung parenchyma than DL and the superficial zone of thermal damage was narrower for TDFL on both days 0 and 7, confirming the effectiveness of both types of laser in cutting and providing hemostasis in the lungs.

Local recurrence after laser-assisted pulmonary metastasectomy

Patients and methods, study design, inclusion and exclusion criteria, data collection and variables definitions, and statistical analysis are reviewed.

References

SHOWING 1-10 OF 23 REFERENCES

Pulmonary metastasectomy - A retrospective comparison of surgical outcomes after laser-assisted and conventional resection.

  • K. FranzkeR. Natanov M. Krüger
  • Medicine
    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
  • 2017

[Pulmonary metastasectomy: an analysis of technical and oncological outcomes in 301 patients with a focus on laser resection].

The number of metastases has an influence on prognosis but seems to be of secondary importance, particularly if complete technical resectability with the aid of the laser is given.

Resection of pulmonary metastases from sarcoma: can some patients benefit from a less invasive approach?

Pulmonary metastasectomy: a multivariate analysis of 440 patients undergoing complete resection.

The decision to consider a patient for resection of metastastic disease should include factors beyond the feasibility of complete removal, and the benefit of such an aggressive surgical approach is only limited to selected subgroups of patients.

Pulmonary metastasectomy for osteogenic and soft tissue sarcoma: who really benefits from surgical treatment?

  • T. MizunoT. Taniguchi K. Yokoi
  • Medicine
    European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
  • 2013
The survival of those patients with one or two pulmonary nodules and those who underwent complete resection was favourable following the treatment of osteogenic and soft tissue sarcomas with PM, and redo surgery may also provide some survival benefit in patients with poor prognostic factors.

Pulmonary resection of metastatic sarcoma: prognostic factors associated with improved outcomes.

Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases.

Resection of pulmonary and extrapulmonary sarcomatous metastases is associated with long-term survival.

Pulmonary metastasectomy for sarcoma: a systematic review of reported outcomes in the context of Thames Cancer Registry data

The 5 year survival rate among sarcoma patients who are selected to have pulmonary metastasectomy is higher than that observed among unselected registry data for patients with any metastatic disease at diagnosis.

Factors associated with actual long-term survival following soft tissue sarcoma pulmonary metastasectomy.

  • R. SmithY. PakW. KraybillJ. Kane
  • Medicine
    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
  • 2009